LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361,142 | -53.3% | 331,323 | -1.9% | 0.00% | – |
| Q2 2023 | $773,275 | +0.2% | 337,675 | +6.4% | 0.00% | – |
| Q1 2023 | $771,530 | +23.9% | 317,502 | -2.6% | 0.00% | – |
| Q4 2022 | $622,694 | -10.9% | 326,018 | +11.8% | 0.00% | – |
| Q3 2022 | $699,000 | +46.2% | 291,660 | +13.4% | 0.00% | – |
| Q2 2022 | $478,000 | -19.7% | 257,096 | -9.7% | 0.00% | – |
| Q1 2022 | $595,000 | -46.9% | 284,610 | +0.1% | 0.00% | – |
| Q4 2021 | $1,120,000 | -10.8% | 284,248 | +8.9% | 0.00% | – |
| Q3 2021 | $1,255,000 | +13.4% | 260,990 | +8.1% | 0.00% | – |
| Q2 2021 | $1,107,000 | -6.3% | 241,335 | +19.8% | 0.00% | – |
| Q1 2021 | $1,182,000 | +84.4% | 201,416 | +7.4% | 0.00% | – |
| Q4 2020 | $641,000 | -12.6% | 187,595 | -63.2% | 0.00% | – |
| Q3 2020 | $733,000 | -35.6% | 509,266 | -10.9% | 0.00% | – |
| Q2 2020 | $1,139,000 | -21.7% | 571,351 | -23.4% | 0.00% | – |
| Q1 2020 | $1,455,000 | -55.9% | 746,265 | -6.1% | 0.00% | -100.0% |
| Q4 2019 | $3,299,000 | +492.3% | 794,876 | +329.0% | 0.00% | – |
| Q3 2019 | $557,000 | -53.6% | 185,265 | -2.9% | 0.00% | – |
| Q2 2019 | $1,200,000 | +10.0% | 190,889 | -2.7% | 0.00% | – |
| Q1 2019 | $1,091,000 | -12.3% | 196,201 | +4.7% | 0.00% | – |
| Q4 2018 | $1,244,000 | -38.2% | 187,403 | -0.7% | 0.00% | -100.0% |
| Q3 2018 | $2,014,000 | -14.4% | 188,739 | -3.8% | 0.00% | 0.0% |
| Q2 2018 | $2,354,000 | +34.7% | 196,210 | -3.7% | 0.00% | – |
| Q1 2018 | $1,748,000 | -11.7% | 203,827 | +1.8% | 0.00% | -100.0% |
| Q4 2017 | $1,979,000 | -20.7% | 200,248 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $2,497,000 | -40.7% | 203,117 | -20.6% | 0.00% | 0.0% |
| Q2 2017 | $4,208,000 | +4.7% | 255,872 | -8.7% | 0.00% | 0.0% |
| Q1 2017 | $4,018,000 | +11.3% | 280,253 | +7.3% | 0.00% | 0.0% |
| Q4 2016 | $3,611,000 | -17.0% | 261,077 | +8.4% | 0.00% | 0.0% |
| Q3 2016 | $4,353,000 | +56.2% | 240,922 | +24.1% | 0.00% | 0.0% |
| Q2 2016 | $2,786,000 | +18.8% | 194,166 | -1.1% | 0.00% | 0.0% |
| Q1 2016 | $2,346,000 | -12.3% | 196,264 | -2.3% | 0.00% | 0.0% |
| Q4 2015 | $2,675,000 | +23.3% | 200,950 | -0.5% | 0.00% | 0.0% |
| Q3 2015 | $2,169,000 | +17.2% | 201,989 | -12.1% | 0.00% | 0.0% |
| Q2 2015 | $1,850,000 | – | 229,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |